Pfizer Inc. (PFE)

• Annual Data
• Quarterly Data

Pfizer Inc., consolidated cash flow statement

US$ in millions

	12 months ended	Dec 31, 2018		Dec 31, 2017		Dec 31, 2016		Dec 31, 2015		Dec 31, 2014
	Net income before allocation to noncontrolling interests
	Depreciation and amortization
	Asset write-offs and impairments
	Foreign currency loss related to Venezuela
	(Gain) loss on disposal of discontinued operations
	Loss on sale of HIS net assets
	TCJA impact
	Deferred taxes from continuing operations
	Deferred taxes from discontinued operations
	Share-based compensation expense
	Benefit plan contributions in excess of expense
	Other adjustments, net
	Trade accounts receivable
	Inventories
	Other assets
	Trade accounts payable
	Other liabilities
	Other tax accounts, net
	Changes in assets and liabilities, net of acquisitions and divestitures
	Adjustments to reconcile net income before allocation to noncontrolling interests to net cash provided by operating activities
	Net cash provided by operating activities
	Purchases of property, plant and equipment
	Purchases of short-term investments
	Proceeds from redemptions/sales of short-term investments
	Net (purchases of) proceeds from redemptions/sales of short-term investments with original maturities of three months or less
	Purchases of long-term investments
	Proceeds from redemptions/sales of long-term investments
	Acquisitions of businesses, net of cash acquired
	Acquisitions of intangible assets
	Other investing activities, net
	Net cash (used in) provided by investing activities
	Proceeds from short-term borrowings
	Principal payments on short-term borrowings
	Net proceeds from (payments on) short-term borrowings with original maturities of three months or less
	Proceeds from issuances of long-term debt
	Principal payments on long-term debt
	Purchases of common stock
	Cash dividends paid
	Proceeds from exercise of stock options
	Other financing activities, net
	Net cash used in financing activities
	Effect of exchange-rate changes on cash and cash equivalents and restricted cash and cash equivalents
	Net increase (decrease) in cash and cash equivalents and restricted cash and cash equivalents
	Cash and cash equivalents and restricted cash and cash equivalents, beginning
	Cash and cash equivalents and restricted cash and cash equivalents, end

Based on: 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29), 10-K (filing date: 2015-02-27).